Chrysalis Technologies is a subsidiary of the Altria Group, a company that is now operating as a division of Philip Morris, and has developed a soft mist aerosol technology for pulmonary drug delivery.
Controversies
According to Dr.Anthony Farone who has a Ph.D. in Physical Chemistry , an M.S. in Chemistry, and worked for Phillip Morris from 1976-1984 as Director of Applied Research, this inhaler could be used as a nicotine inhaler and could put an end to cigarette smoking, he stated that this just won't happen because the cigarette companies that developed it would lose all of their profits.
Comments